IL10 and metabolic dysfunction-associated steatohepatitis: Findings in a rat model of NASH indicates that this may occur through reduced liver concentrations of the pro-inflammatory cytokines tumour necrosis factor alpha and transforming growth factor β (TGF-β), with an increase in anti-inflammatory cytokines interleukin-4 and interleukin-10 [42].